| Year |
Citation |
Score |
| 2023 |
Huang Y, Gu S, Han Z, Yang Z, Zhong L, Li L, Wang R, Yan F, Luo Y, Borlongan C, Lu J. Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke. Journal of the American Heart Association. 12: e029817. PMID 37655472 DOI: 10.1161/JAHA.123.029817 |
0.365 |
|
| 2022 |
Monsour M, Croci DM, Agazzi S, Borlongan CV. Getting the guts to expand stroke treatment: The potential for microbiome targeted therapies. Cns Neuroscience & Therapeutics. PMID 36217699 DOI: 10.1111/cns.13988 |
0.366 |
|
| 2022 |
Kawauchi S, Yasuhara T, Kin K, Yabuno S, Sugahara C, Nagase T, Hosomoto K, Okazaki Y, Tomita Y, Umakoshi M, Sasaki T, Kameda M, Borlongan CV, Date I. Transplantation of modified human bone marrow-derived stromal cells affords therapeutic effects on cerebral ischemia in rats. Cns Neuroscience & Therapeutics. PMID 36000240 DOI: 10.1111/cns.13947 |
0.369 |
|
| 2022 |
Helsper S, Yuan X, Bagdasarian FA, Athey J, Li Y, Borlongan CV, Grant SC. Multinuclear MRI Reveals Early Efficacy of Stem Cell Therapy in Stroke. Translational Stroke Research. PMID 35900719 DOI: 10.1007/s12975-022-01057-w |
0.385 |
|
| 2022 |
Gordon J, Lockard G, Monsour M, Alayli A, Borlongan CV. The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease. Antioxidants (Basel, Switzerland). 11. PMID 35892653 DOI: 10.3390/antiox11081447 |
0.353 |
|
| 2022 |
Anthony S, Cabantan D, Monsour M, Borlongan CV. Neuroinflammation, Stem Cells, and Stroke. Stroke. 101161STROKEAHA12103. PMID 35380050 DOI: 10.1161/STROKEAHA.121.036948 |
0.458 |
|
| 2022 |
Lee JY, Castelli V, Kumar N, Sitruk-Ware R, Borlongan CV. Contraceptive drug, Nestorone, enhances stem cell-mediated remodeling of the stroke brain by dampening inflammation and rescuing mitochondria. Free Radical Biology & Medicine. 183: 138-145. PMID 35341914 DOI: 10.1016/j.freeradbiomed.2022.03.020 |
0.434 |
|
| 2022 |
Brooks B, Ebedes D, Usmani A, Gonzales-Portillo JV, Gonzales-Portillo D, Borlongan CV. Mesenchymal Stromal Cells in Ischemic Brain Injury. Cells. 11. PMID 35326464 DOI: 10.3390/cells11061013 |
0.498 |
|
| 2022 |
Helsper S, Bagdasarian FA, Yuan X, Xu K, Lee JY, Rosenberg JT, Borlongan CV, Ma T, Grant SC. Extended Ischemic Recovery After Implantation of Human Mesenchymal Stem Cell Aggregates Indicated by Sodium MRI at 21.1 T. Translational Stroke Research. PMID 35132543 DOI: 10.1007/s12975-021-00976-4 |
0.345 |
|
| 2021 |
Sadanandan N, Shear A, Brooks B, Saft M, Cabantan DAG, Kingsbury C, Zhang H, Anthony S, Wang ZJ, Salazar FE, Lezama Toledo AR, Rivera Monroy G, Vega Gonzales-Portillo J, Moscatello A, Lee JY, ... Borlongan CV, et al. Treating Metastatic Brain Cancers With Stem Cells. Frontiers in Molecular Neuroscience. 14: 749716. PMID 34899179 DOI: 10.3389/fnmol.2021.749716 |
0.309 |
|
| 2021 |
Berlet R, Anthony S, Brooks B, Wang ZJ, Sadanandan N, Shear A, Cozene B, Gonzales-Portillo B, Parsons B, Salazar FE, Lezama Toledo AR, Monroy GR, Gonzales-Portillo JV, Borlongan CV. Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke. Biomolecules. 11. PMID 34572529 DOI: 10.3390/biom11091316 |
0.456 |
|
| 2021 |
Kingsbury C, Shear A, Heyck M, Sadanandan N, Zhang H, Gonzales-Portillo B, Cozene B, Sheyner M, Navarro-Torres L, García-Sánchez J, Lee JY, Borlongan CV. Inflammation-relevant microbiome signature of the stroke brain, gut, spleen, and thymus and the impact of exercise. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211039598. PMID 34427146 DOI: 10.1177/0271678X211039598 |
0.351 |
|
| 2021 |
Watanabe S, Masuda S, Shinozuka K, Borlongan C. Preference and discrimination of facial expressions of humans, rats, and mice by C57 mice. Animal Cognition. PMID 34417921 DOI: 10.1007/s10071-021-01551-y |
0.737 |
|
| 2021 |
Park YJ, Borlongan CV. Recent advances in cell therapy for stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211026507. PMID 34187231 DOI: 10.1177/0271678X211026507 |
0.47 |
|
| 2021 |
Saft M, Koga M, Borlongan CV. Bone marrow-derived NCS-01 cells for ischemic stroke. Brain Circulation. 7: 44-47. PMID 34084978 DOI: 10.4103/bc.bc_23_21 |
0.451 |
|
| 2021 |
Gonzales-Portillo BM, Lee JY, Vandenbark AA, Offner H, Borlongan CV. Major histocompatibility complex Class II-based therapy for stroke. Brain Circulation. 7: 37-40. PMID 34084976 DOI: 10.4103/bc.bc_16_21 |
0.362 |
|
| 2021 |
Cozene BM, Russo E, Anzalone R, Rocca G, Borlongan CV. Mitochondrial activity of human umbilical cord mesenchymal stem cells. Brain Circulation. 7: 33-36. PMID 34084975 DOI: 10.4103/bc.bc_15_21 |
0.312 |
|
| 2021 |
Park YJ, Borlongan CV, Dezawa M. Cell-based treatment for perinatal hypoxic-ischemic encephalopathy. Brain Circulation. 7: 13-17. PMID 34084971 DOI: 10.4103/bc.bc_7_21 |
0.398 |
|
| 2021 |
Sadanandan N, Cozene B, Park YJ, Farooq J, Kingsbury C, Wang ZJ, Moscatello A, Saft M, Cho J, Gonzales-Portillo B, Borlongan CV. Pituitary Adenylate Cyclase-Activating Polypeptide: A Potent Therapeutic Agent in Oxidative Stress. Antioxidants (Basel, Switzerland). 10. PMID 33653014 DOI: 10.3390/antiox10030354 |
0.35 |
|
| 2021 |
Cho J, Park YJ, Gonzales-Portillo B, Saft M, Cozene B, Sadanandan N, Borlongan CV. Gut dysbiosis in stroke and its implications on Alzheimer's disease-like cognitive dysfunction. Cns Neuroscience & Therapeutics. PMID 33464726 DOI: 10.1111/cns.13613 |
0.324 |
|
| 2020 |
Corey S, Bonsack B, Heyck M, Shear A, Sadanandan N, Zhang H, Borlongan CV. Harnessing the anti-inflammatory properties of stem cells for transplant therapy in hemorrhagic stroke. Brain Hemorrhages. 1: 24-33. PMID 34056567 DOI: 10.1016/j.hest.2019.12.005 |
0.454 |
|
| 2020 |
Suzuki T, Sato Y, Kushida Y, Tsuji M, Wakao S, Ueda K, Imai K, Iitani Y, Shimizu S, Hida H, Temma T, Saito S, Iida H, Mizuno M, Takahashi Y, ... ... Borlongan CV, et al. Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20972656. PMID 33222596 DOI: 10.1177/0271678X20972656 |
0.391 |
|
| 2020 |
Fan J, Saft M, Sadanandan N, Gonzales-Portillo B, Park YJ, Sanberg PR, Borlongan CV, Luo Y. LncRNAs Stand as Potent Biomarkers and Therapeutic Targets for Stroke. Frontiers in Aging Neuroscience. 12: 594571. PMID 33192490 DOI: 10.3389/fnagi.2020.594571 |
0.355 |
|
| 2020 |
Park YJ, Farooq J, Cho J, Cozene B, Gonzales-Portillo B, Sadanandan N, Saft M, Lee JY, Borlongan CV. A Museum of Stem Cells Points to Muse Cells as Robust Transplantable Cells for Stroke: Review. Advances in Experimental Medicine and Biology. PMID 33159307 DOI: 10.1007/5584_2020_596 |
0.454 |
|
| 2020 |
Castelli V, Antonucci I, d'Angelo M, Tessitore A, Zelli V, Benedetti E, Ferri C, Desideri G, Borlongan C, Stuppia L, Cimini A. Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model. Stem Cells Translational Medicine. 10: 251-266. PMID 33027557 DOI: 10.1002/sctm.20-0268 |
0.366 |
|
| 2020 |
Saft M, Gonzales-Portillo B, Park YJ, Cozene B, Sadanandan N, Cho J, Garbuzova-Davis S, Borlongan CV. Stem Cell Repair of the Microvascular Damage in Stroke. Cells. 9. PMID 32932814 DOI: 10.3390/cells9092075 |
0.458 |
|
| 2020 |
Cozene B, Sadanandan N, Gonzales-Portillo B, Saft M, Cho J, Park YJ, Borlongan CV. An Extra Breath of Fresh Air: Hyperbaric Oxygenation as a Stroke Therapeutic. Biomolecules. 10. PMID 32899709 DOI: 10.3390/biom10091279 |
0.37 |
|
| 2020 |
Park YJ, Niizuma K, Mokin M, Dezawa M, Borlongan CV. Cell-Based Therapy for Stroke: Musing With Muse Cells. Stroke. STROKEAHA120030618. PMID 32811374 DOI: 10.1161/STROKEAHA.120.030618 |
0.472 |
|
| 2020 |
Sadanandan N, Cozene B, Cho J, Park YJ, Saft M, Gonzales-Portillo B, Borlongan CV. Melatonin-A Potent Therapeutic for Stroke and Stroke-Related Dementia. Antioxidants (Basel, Switzerland). 9. PMID 32731545 DOI: 10.3390/antiox9080672 |
0.394 |
|
| 2020 |
Farooq J, Park YJ, Cho J, Saft M, Sadanandan N, Cozene B, Borlongan CV. Stem Cells as Drug-like Biologics for Mitochondrial Repair in Stroke. Pharmaceutics. 12. PMID 32630218 DOI: 10.3390/pharmaceutics12070615 |
0.366 |
|
| 2020 |
Bonsack B, Corey S, Shear A, Heyck M, Cozene B, Sadanandan N, Zhang H, Gonzales-Portillo B, Sheyner M, Borlongan CV. Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury. Cns Neuroscience & Therapeutics. PMID 32356605 DOI: 10.1111/cns.13378 |
0.481 |
|
| 2020 |
Brown J, Park YJ, Lee JY, Chase TN, Koga M, Borlongan CV. Bone Marrow-Derived NCS-01 Cells Advance a Novel Cell-Based Therapy for Stroke. International Journal of Molecular Sciences. 21. PMID 32325813 DOI: 10.3390/ijms21082845 |
0.465 |
|
| 2020 |
Brown J, Kingsbury C, Lee JY, Vandenbark AA, Meza-Romero R, Offner H, Borlongan CV. Spleen participation in partial MHC class II construct neuroprotection in stroke. Cns Neuroscience & Therapeutics. PMID 32237074 DOI: 10.1111/Cns.13369 |
0.334 |
|
| 2020 |
Russo E, Lee JY, Nguyen H, Corrao S, Anzalone R, La Rocca G, Borlongan CV. Energy Metabolism Analysis of Three Different Mesenchymal Stem Cell Populations of Umbilical Cord Under Normal and Pathologic Conditions. Stem Cell Reviews and Reports. PMID 32185666 DOI: 10.1007/s12015-020-09967-8 |
0.335 |
|
| 2020 |
Bonsack B, Jiang RH, Borlongan CV. A gut feeling about stroke reveals gut-brain axis' active role in homeostasis and dysbiosis. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19900037. PMID 32063084 DOI: 10.1177/0271678X19900037 |
0.331 |
|
| 2020 |
Bonsack B, Heyck M, Kingsbury C, Cozene B, Sadanandan N, Lee JY, Borlongan CV. Fast-tracking regenerative medicine for traumatic brain injury. Neural Regeneration Research. 15: 1179-1190. PMID 31960797 DOI: 10.4103/1673-5374.270294 |
0.337 |
|
| 2020 |
Kingsbury C, Heyck M, Bonsack B, Lee JY, Borlongan CV. Stroke gets in your eyes: stroke-induced retinal ischemia and the potential of stem cell therapy. Neural Regeneration Research. 15: 1014-1018. PMID 31823871 DOI: 10.4103/1673-5374.270293 |
0.393 |
|
| 2020 |
Borlongan CV, Jolkkonen J, Detante O. The future of stem cell therapy for stroke rehabilitation. Future Neurology. 10: 313-319. PMID 26997918 DOI: 10.2217/FNL.15.27 |
0.418 |
|
| 2019 |
Bonsack B, Kingsbury C, Brown J, Borlongan CV. Editorial: Mechanistic Underpinnings Of Stem Cell Therapy For Neurological Disorders. Brain Research. 146643. PMID 31901430 DOI: 10.1016/j.brainres.2019.146643 |
0.321 |
|
| 2019 |
Tuazon JP, Castelli V, Lee JY, Desideri GB, Stuppia L, Cimini AM, Borlongan CV. Neural Stem Cells. Advances in Experimental Medicine and Biology. 1201: 79-91. PMID 31898782 DOI: 10.1007/978-3-030-31206-0_4 |
0.349 |
|
| 2019 |
Abe T, Aburakawa D, Niizuma K, Iwabuchi N, Kajitani T, Wakao S, Kushida Y, Dezawa M, Borlongan CV, Tominaga T. Intravenously Transplanted Human Multilineage-Differentiating Stress-Enduring Cells Afford Brain Repair in a Mouse Lacunar Stroke Model. Stroke. 51: 601-611. PMID 31826733 DOI: 10.1161/STROKEAHA.119.026589 |
0.345 |
|
| 2019 |
Lee JY, Castelli V, Bonsack B, Coats AB, Navarro-Torres L, Garcia-Sanchez J, Kingsbury C, Nguyen H, Vandenbark AA, Meza-Romero R, Offner H, Borlongan CV. A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental Stroke. Translational Stroke Research. PMID 31797249 DOI: 10.1007/S12975-019-00756-1 |
0.358 |
|
| 2019 |
Kaneko Y, Lee JY, Tajiri N, Tuazon JP, Lippert T, Russo E, Yu SJ, Bonsack B, Corey S, Coats AB, Kingsbury C, Chase TN, Koga M, Borlongan CV. Translating intracarotid artery transplantation of bone marrow-derived NCS-01 cells for ischemic stroke: Behavioral and histological readouts and mechanistic insights into stem cell therapy. Stem Cells Translational Medicine. PMID 31738023 DOI: 10.1002/sctm.19-0229 |
0.461 |
|
| 2019 |
Yasuhara T, Kawauchi S, Kin K, Morimoto J, Kameda M, Sasaki T, Bonsack B, Kingsbury C, Tajiri N, Borlongan CV, Date I. Cell therapy for central nervous system disorders: Current obstacles to progress. Cns Neuroscience & Therapeutics. PMID 31622035 DOI: 10.1111/cns.13247 |
0.405 |
|
| 2019 |
Zhang H, Lee JY, Borlongan CV, Tajiri N. A brief physical activity protects against ischemic stroke. Brain Circulation. 5: 112-118. PMID 31620657 DOI: 10.4103/bc.bc_32_19 |
0.345 |
|
| 2019 |
Gonzales-Portillo B, Lippert T, Nguyen H, Lee JY, Borlongan CV. Hyperbaric oxygen therapy: A new look on treating stroke and traumatic brain injury. Brain Circulation. 5: 101-105. PMID 31620655 DOI: 10.4103/bc.bc_31_19 |
0.372 |
|
| 2019 |
Zhang Y, Ma L, Su Y, Su L, Lan X, Wu D, Han S, Li J, Kvederis L, Corey S, Borlongan CV, Ji X. Hypoxia conditioning enhances neuroprotective effects of aged human bone marrow mesenchymal stem cell-derived conditioned medium against cerebral ischemia in vitro. Brain Research. 146432. PMID 31491422 DOI: 10.1016/j.brainres.2019.146432 |
0.301 |
|
| 2019 |
Corey S, Abraham DI, Kaneko Y, Lee JY, Borlongan CV. Selective endovascular cooling for stroke entails brain-derived neurotrophic factor and splenic IL-10 modulation. Brain Research. 146380. PMID 31415765 DOI: 10.1016/j.brainres.2019.146380 |
0.373 |
|
| 2019 |
Shinozuka K, Tajiri N, Ishikawa H, Tuazon JP, Lee JY, Sanberg PR, Zarriello S, Corey S, Kaneko Y, Borlongan CV. Empathy in stroke rats is modulated by social settings. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19867908. PMID 31366299 DOI: 10.1177/0271678X19867908 |
0.799 |
|
| 2019 |
Tuazon JP, Castelli V, Borlongan CV. Drug-like delivery methods of stem cells as biologics for stroke. Expert Opinion On Drug Delivery. 16: 823-833. PMID 31311344 DOI: 10.1080/17425247.2019.1645116 |
0.443 |
|
| 2019 |
Tuazon JP, Sitruk-Ware R, Borlongan CV. Reprint of: Beyond contraception and hormone replacement therapy: Advancing Nestorone to a neuroprotective drug in the clinic. Brain Research. PMID 31213288 DOI: 10.1016/j.brainres.2019.05.038 |
0.366 |
|
| 2019 |
Borlongan CV. Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet? Stem Cells Translational Medicine. PMID 31099181 DOI: 10.1002/sctm.19-0076 |
0.454 |
|
| 2019 |
Pianta S, Lee JY, Tuazon JP, Castelli V, Mantohac LM, Tajiri N, Borlongan CV. A Short Bout of Exercise Prior to Stroke Improves Functional Outcomes by Enhancing Angiogenesis. Neuromolecular Medicine. PMID 30941660 DOI: 10.1007/s12017-019-08533-x |
0.316 |
|
| 2019 |
Lee JY, Acosta S, Tuazon JP, Xu K, Nguyen H, Lippert T, Liska MG, Semechkin A, Garitaonandia I, Gonzalez R, Kern R, Borlongan CV. Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model. Theranostics. 9: 1029-1046. PMID 30867814 DOI: 10.7150/Thno.29868 |
0.333 |
|
| 2019 |
Acosta SA, Lee JY, Nguyen H, Kaneko Y, Borlongan CV. Endothelial Progenitor Cells Modulate Inflammation-Associated Stroke Vasculome. Stem Cell Reviews. PMID 30739275 DOI: 10.1007/s12015-019-9873-x |
0.401 |
|
| 2019 |
Zhang Y, Yu S, Tuazon JP, Lee JY, Corey S, Kvederis L, Kingsbury C, Kaneko Y, Borlongan CV. Neuroprotective effects of human bone marrow mesenchymal stem cells against cerebral ischemia are mediated in part by an anti-apoptotic mechanism. Neural Regeneration Research. 14: 597-604. PMID 30632499 DOI: 10.4103/1673-5374.247464 |
0.307 |
|
| 2019 |
Niizuma K, Borlongan CV, Tominaga T. Application of Muse Cell Therapy to Stroke. Advances in Experimental Medicine and Biology. 1103: 167-186. PMID 30484229 DOI: 10.1007/978-4-431-56847-6_9 |
0.453 |
|
| 2019 |
Napoli E, Lippert T, Borlongan CV. Stem Cell Therapy: Repurposing Cell-Based Regenerative Medicine Beyond Cell Replacement. Advances in Experimental Medicine and Biology. 1079: 87-91. PMID 29480446 DOI: 10.1007/5584_2018_174 |
0.379 |
|
| 2018 |
Zhang Y, Ma L, Ren C, Liu K, Tian X, Wu D, Ding Y, Li J, Borlongan CV, Ji X. Immediate remote ischemic postconditioning reduces cerebral damage in ischemic stroke mice by enhancing leptomeningeal collateral circulation. Journal of Cellular Physiology. PMID 30536714 DOI: 10.1002/jcp.27858 |
0.338 |
|
| 2018 |
Xu K, Lee JY, Kaneko Y, Tuazon JP, Vale F, van Loveren H, Borlongan CV. Human stem cells transplanted into the rat stroke brain migrate to spleen via lymphatic and inflammation pathways. Haematologica. PMID 30514806 DOI: 10.3324/haematol.2018.206581 |
0.46 |
|
| 2018 |
Incontri Abraham D, Gonzales M, Ibarra A, Borlongan CV. Stand Alone or Join Forces? Stem Cell Therapy for Stroke. Expert Opinion On Biological Therapy. PMID 30477353 DOI: 10.1080/14712598.2019.1551872 |
0.424 |
|
| 2018 |
Knecht T, Borlongan C, Dela Peña I. Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator. Brain Circulation. 4: 99-108. PMID 30450415 DOI: 10.4103/bc.bc_21_18 |
0.352 |
|
| 2018 |
Russo E, Napoli E, Borlongan CV. Healthy mitochondria for stroke cells. Brain Circulation. 4: 95-98. PMID 30450414 DOI: 10.4103/bc.bc_20_18 |
0.381 |
|
| 2018 |
Russo E, Nguyen H, Lippert T, Tuazon J, Borlongan CV, Napoli E. Mitochondrial targeting as a novel therapy for stroke. Brain Circulation. 4: 84-94. PMID 30450413 DOI: 10.4103/bc.bc_14_18 |
0.394 |
|
| 2018 |
Borlongan CV, Nguyen H, Lippert T, Russo E, Tuazon J, Xu K, Lee JY, Sanberg PR, Kaneko Y, Napoli E. May the force be with you: Transfer of healthy mitochondria from stem cells to stroke cells. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18811277. PMID 30375940 DOI: 10.1177/0271678X18811277 |
0.421 |
|
| 2018 |
Tuazon JP, Sitruk-Ware R, Borlongan CV. Beyond contraception and hormone replacement therapy: advancing Nestorone to a neuroprotective drug in the clinic. Brain Research. PMID 30321495 DOI: 10.1016/j.brainres.2018.10.014 |
0.366 |
|
| 2018 |
Nguyen H, Zarriello S, Coats A, Nelson C, Kingsbury C, Gorsky A, Rajani M, Neal EG, Borlongan CV. Stem cell therapy for neurological disorders: A focus on aging. Neurobiology of Disease. PMID 30219376 DOI: 10.1016/j.nbd.2018.09.011 |
0.323 |
|
| 2018 |
Nguyen H, Zarriello S, Rajani M, Tuazon J, Napoli E, Borlongan CV. Understanding the Role of Dysfunctional and Healthy Mitochondria in Stroke Pathology and Its Treatment. International Journal of Molecular Sciences. 19. PMID 30037107 DOI: 10.3390/ijms19072127 |
0.437 |
|
| 2018 |
Neal EG, Liska MG, Lippert T, Lin R, Gonzalez M, Russo E, Xu K, Ji X, Vale F, van Loveren H, Borlongan CV. An update on intracerebral stem cell grafts. Expert Review of Neurotherapeutics. PMID 29961357 DOI: 10.1080/14737175.2018.1491309 |
0.352 |
|
| 2018 |
Dela Peña IC, Yang S, Shen G, Fang Liang H, Solak S, Borlongan CV. Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke. International Journal of Molecular Sciences. 19. PMID 29857523 DOI: 10.3390/ijms19061635 |
0.334 |
|
| 2018 |
Morimoto J, Yasuhara T, Kameda M, Umakoshi M, Kin I, Kuwahara K, Kin K, Okazaki M, Takeuchi H, Sasaki T, Toyoshima A, Tajiri N, Agari T, Borlongan CV, Date I. Electrical Stimulation Enhances Migratory Ability of Transplanted Bone Marrow Stromal Cells in a Rodent Ischemic Stroke Model. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 46: 57-68. PMID 29587284 DOI: 10.1159/000488409 |
0.348 |
|
| 2018 |
Neal EG, Acosta SA, Kaneko Y, Ji X, Borlongan CV. Regulatory T-cells within bone marrow-derived stem cells actively confer immunomodulatory and neuroprotective effects against stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18766172. PMID 29569981 DOI: 10.1177/0271678X18766172 |
0.397 |
|
| 2018 |
Lee JY, Lin R, Nguyen H, Grant Liska M, Lippert T, Kaneko Y, Borlongan CV. Histopathological and Behavioral Assessments of Aging Effects on Stem Cell Transplants in an Experimental Traumatic Brain Injury. Methods in Molecular Biology (Clifton, N.J.). PMID 29445958 DOI: 10.1007/7651_2018_121 |
0.32 |
|
| 2018 |
Napoli E, Borlongan CV. Cell Therapy in Parkinson's Disease: Host Brain Repair Machinery Gets a Boost From Stem Cell Grafts. Stem Cells (Dayton, Ohio). 35: 1443-1445. PMID 28480563 DOI: 10.1002/stem.2636 |
0.341 |
|
| 2018 |
Borlongan CV. Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients. Molecular Therapy : the Journal of the American Society of Gene Therapy. 24: 1710-1711. PMID 27818493 DOI: 10.1038/mt.2016.186 |
0.379 |
|
| 2017 |
Knecht T, Story J, Liu J, Davis W, Borlongan CV, Dela Peña IC. Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment. International Journal of Molecular Sciences. 18. PMID 29257093 DOI: 10.3390/ijms18122756 |
0.321 |
|
| 2017 |
Lee JY, Liska MG, Crowley M, Xu K, Acosta SA, Borlongan CV, Guedes VA. Multifaceted Effects of Delta Opioid Receptors and DADLE in Diseases of the Nervous System. Current Drug Discovery Technologies. PMID 29032758 DOI: 10.2174/1570163814666171010114403 |
0.315 |
|
| 2017 |
Stonesifer C, Corey S, Ghanekar S, Diamandis Z, Acosta SA, Borlongan CV. Stem Cell Therapy for Abrogating Stroke-Induced Neuroinflammation and Relevant Secondary Cell Death Mechanisms. Progress in Neurobiology. PMID 28743464 DOI: 10.1016/j.pneurobio.2017.07.004 |
0.444 |
|
| 2017 |
Lee JY, Xu K, Nguyen H, Guedes VA, Borlongan CV, Acosta SA. Stem Cell-Induced Biobridges as Possible Tools to Aid Neuroreconstruction after CNS Injury. Frontiers in Cell and Developmental Biology. 5: 51. PMID 28540289 DOI: 10.3389/fcell.2017.00051 |
0.365 |
|
| 2017 |
Li H, Wu J, Shen H, Yao X, Liu C, Pianta S, Han J, Borlongan CV, Chen G. Autophagy in hemorrhagic stroke: mechanisms and clinical implications. Progress in Neurobiology. PMID 28414101 DOI: 10.1016/j.pneurobio.2017.04.002 |
0.362 |
|
| 2017 |
Tajiri N, Quach DM, Kaneko Y, Wu S, Lee D, Lam T, Hayama KL, Hazel TG, Johe K, Wu MC, Borlongan CV. NSI-189, a Small Molecule with Neurogenic Properties, Exerts Behavioral and Neurostructural Benefits in Stroke Rats. Journal of Cellular Physiology. PMID 28181668 DOI: 10.1002/Jcp.25847 |
0.39 |
|
| 2017 |
Peña ID, Borlongan C, Shen G, Davis W. Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need. Journal of Stroke. 19: 50-60. PMID 28178410 DOI: 10.5853/jos.2016.01515 |
0.316 |
|
| 2017 |
Garbuzova-Davis S, Haller E, Lin R, Borlongan CV. Intravenously Transplanted Human Bone Marrow Endothelial Progenitor Cells Engraft Within Brain Capillaries, Preserve Mitochondrial Morphology, and Display Pinocytotic Activity Towards BBB Repair in Ischemic Stroke Rats. Stem Cells (Dayton, Ohio). PMID 28142208 DOI: 10.1002/stem.2578 |
0.444 |
|
| 2017 |
Liska MG, Crowley MG, Borlongan CV. Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke. Translational Stroke Research. 8: 93-103. PMID 28127687 DOI: 10.1007/s12975-017-0522-x |
0.378 |
|
| 2017 |
Napoli E, Borlongan CV. Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered. Stem Cell Reviews and Reports. 13: 192-197. PMID 28064388 DOI: 10.1007/s12015-016-9716-y |
0.424 |
|
| 2017 |
Uchida H, Niizuma K, Kushida Y, Wakao S, Tominaga T, Borlongan CV, Dezawa M. Human Muse Cells Reconstruct Neuronal Circuitry in Subacute Lacunar Stroke Model. Stroke. 48: 428-435. PMID 27999136 DOI: 10.1161/STROKEAHA.116.014950 |
0.346 |
|
| 2017 |
Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kaneko Y, Borlongan C. Addendum: Shinozuka, K. et al. Stem Cell Transplantation for Neuroprotection in Stroke. Brain Sci. 2013, 3, 239–261 Brain Sciences. 7: 145. DOI: 10.3390/Brainsci7110145 |
0.805 |
|
| 2016 |
Lippert T, Watson N, Ji X, Yasuhara T, Date I, Kaneko Y, Tajiri N, Borlongan CV. Detrimental effects of physical inactivity on neurogenesis. Brain Circulation. 2: 80-85. PMID 30276277 DOI: 10.4103/2394-8108.186278 |
0.312 |
|
| 2016 |
Crowley MG, Liska MG, Borlongan CV. Stem cell therapy for sequestering neuroinflammation in traumatic brain injury: an update on exosome-targeting to the spleen. Journal of Neurosurgical Sciences. 61: 291-302. PMID 27901327 DOI: 10.23736/S0390-5616.16.03921-7 |
0.366 |
|
| 2016 |
Mashkouri S, Crowley MG, Liska MG, Corey S, Borlongan CV. Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injury. Neural Regeneration Research. 11: 1379-1384. PMID 27857726 DOI: 10.4103/1673-5374.191197 |
0.329 |
|
| 2016 |
Rodrigues MC, Lippert T, Nguyen H, Kaelber S, Sanberg PR, Borlongan CV. Menstrual Blood-Derived Stem Cells: In Vitro and In Vivo Characterization of Functional Effects. Advances in Experimental Medicine and Biology. 951: 111-121. PMID 27837558 DOI: 10.1007/978-3-319-45457-3_9 |
0.358 |
|
| 2016 |
Napoli E, Borlongan CV. Recent Advances in Stem Cell-Based Therapeutics for Stroke. Translational Stroke Research. PMID 27515852 DOI: 10.1007/s12975-016-0490-6 |
0.428 |
|
| 2016 |
Borlongan CV. Age of PISCES: stem-cell clinical trials in stroke. Lancet (London, England). 388: 736-8. PMID 27497863 DOI: 10.1016/S0140-6736(16)31259-4 |
0.357 |
|
| 2016 |
Liska MG, Crowley MG, Nguyen H, Borlongan CV. Implication of biobridge concept in stem cell therapy for ischemic stroke. Journal of Neurosurgical Sciences. PMID 27406955 DOI: 10.23736/S0390-5616.16.03791-7 |
0.467 |
|
| 2016 |
Tajiri N, Lee JY, Acosta S, Sanberg PR, Borlongan CV. Breaking the blood brain barrier to aid stem cell therapeutics in the chronic stroke brain. Cell Transplantation. PMID 26883984 DOI: 10.3727/096368916X690971 |
0.469 |
|
| 2016 |
Peña Id, Borlongan CV. Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke. Translational Stroke Research. 6: 421-9. PMID 26482176 DOI: 10.1007/s12975-015-0430-x |
0.465 |
|
| 2016 |
Sokol J, Lippert T, Borlongan CV, Stuppia L. Translating amniotic fluid-derived stem cells for transplantation in stroke Chinese Neurosurgical Journal. 2. DOI: 10.1186/s41016-016-0055-2 |
0.387 |
|
| 2016 |
Gonzales-Portillo C, Ishikawa H, Shinozuka K, Tajiri N, Kaneko Y, Borlongan CV. Stroke and cardiac cell death: Two peas in a pod Clinical Neurology and Neurosurgery. 142: 145-147. DOI: 10.1016/j.clineuro.2016.01.001 |
0.8 |
|
| 2015 |
Uchida H, Morita T, Niizuma K, Kushida Y, Kuroda Y, Wakao S, Sakata H, Matsuzaka Y, Mushiake H, Tominaga T, Borlongan CV, Dezawa M. Transplantation of Unique Subpopulation of Fibroblasts, Muse Cells, Ameliorates Experimental Stroke Possibly Via Robust Neuronal Differentiation. Stem Cells (Dayton, Ohio). PMID 26388204 DOI: 10.1002/stem.2206 |
0.427 |
|
| 2015 |
Toyoshima A, Yasuhara T, Kameda M, Morimoto J, Takeuchi H, Wang F, Sasaki T, Sasada S, Shinko A, Wakamori T, Okazaki M, Kondo A, Agari T, Borlongan CV, Date I. Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms. Plos One. 10: e0127302. PMID 26075717 DOI: 10.1371/journal.pone.0127302 |
0.403 |
|
| 2015 |
Sullivan R, Duncan K, Dailey T, Kaneko Y, Tajiri N, Borlongan CV. A possible new focus for stroke treatment - migrating stem cells. Expert Opinion On Biological Therapy. 15: 949-58. PMID 25943632 DOI: 10.1517/14712598.2015.1043264 |
0.355 |
|
| 2015 |
Watson N, Ji X, Yasuhara T, Date I, Kaneko Y, Tajiri N, Borlongan CV. No pain, no gain: lack of exercise obstructs neurogenesis. Cell Transplantation. 24: 591-7. PMID 25806858 DOI: 10.3727/096368915X687723 |
0.317 |
|
| 2015 |
Duncan K, Gonzales-Portillo GS, Acosta SA, Kaneko Y, Borlongan CV, Tajiri N. Stem cell-paved biobridges facilitate stem transplant and host brain cell interactions for stroke therapy. Brain Research. PMID 25770817 DOI: 10.1016/j.brainres.2015.03.007 |
0.479 |
|
| 2015 |
De La Peña I, Sanberg PR, Acosta S, Lin SZ, Borlongan CV. G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury. Cell Transplantation. 24: 447-57. PMID 25646620 DOI: 10.3727/096368915X686913 |
0.308 |
|
| 2015 |
Zhang Y, Ying G, Ren C, Jizhang Y, Brogan D, Liu Z, Li S, Ding Y, Borlongan CV, Zhang J, Ji X. Administration of human platelet-rich plasma reduces infarction volume and improves motor function in adult rats with focal ischemic stroke. Brain Research. 1594: 267-73. PMID 25452023 DOI: 10.1016/j.brainres.2014.10.035 |
0.351 |
|
| 2015 |
Watson N, Divers R, Kedar R, Mehindru A, Mehindru A, Borlongan MC, Borlongan CV. Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells. Cytotherapy. 17: 18-24. PMID 25442786 DOI: 10.1016/j.jcyt.2014.08.009 |
0.31 |
|
| 2015 |
dela Peña IC, Yoo A, Tajiri N, Acosta SA, Ji X, Kaneko Y, Borlongan CV. Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 338-46. PMID 25425079 DOI: 10.1038/jcbfm.2014.208 |
0.328 |
|
| 2015 |
Pabón MM, Ji XM, Fernandez JW, Borlongan CV. Gender-linked stem cell alterations in stroke and postpartum depression. Cns Neuroscience & Therapeutics. 21: 348-56. PMID 25399760 DOI: 10.1111/Cns.12339 |
0.428 |
|
| 2015 |
Kaneko Y, Tajiri N, Staples M, Reyes S, Lozano D, Sanberg PR, Freeman TB, van Loveren H, Kim SU, Borlongan CV. Bone marrow-derived stem cell therapy for metastatic brain cancers. Cell Transplantation. 24: 625-30. PMID 25310691 DOI: 10.3727/096368914X685096 |
0.301 |
|
| 2015 |
Borlongan C, Diaco N, Diamandis Z. Amniotic fluid-derived stem cells as an effective cell source for transplantation therapy in stroke Brain Circulation. 1: 119. DOI: 10.4103/2394-8108.172881 |
0.408 |
|
| 2015 |
Elias M, Hoover J, Nguyen H, Reyes S, Lawton C, Borlongan CV. Stroke therapy: The potential of amniotic fluid-derived stem cells Future Neurology. 10: 321-326. DOI: 10.2217/fnl.15.19 |
0.392 |
|
| 2015 |
Acosta SA, Tajiri N, Hoover J, Kaneko Y, Borlongan CV. Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke Stroke. 46: 2616-2627. DOI: 10.1161/STROKEAHA.115.009854 |
0.333 |
|
| 2015 |
Rodrigues MCO, Garbuzova-Davis SN, Cruz LE, Sanberg PR, Voltarelli JC, Allickson JG, Borlongan CV. Menstrual blood transplantation therapy for stroke and other neurological disorders Regenerative Medicine: Using Non-Fetal Sources of Stem Cells. 45-53. DOI: 10.1007/978-1-4471-6542-2_6 |
0.422 |
|
| 2014 |
Diamandis T, Borlongan CV. One, two, three steps toward cell therapy for stroke. Stroke. 46: 588-91. PMID 25503552 DOI: 10.1161/STROKEAHA.114.007105 |
0.371 |
|
| 2014 |
Tajiri N, Duncan K, Borlongan MC, Pabon M, Acosta S, de la Pena I, Hernadez-Ontiveros D, Lozano D, Aguirre D, Reyes S, Sanberg PR, Eve DJ, Borlongan CV, Kaneko Y. Adult stem cell transplantation: is gender a factor in stemness? International Journal of Molecular Sciences. 15: 15225-43. PMID 25170809 DOI: 10.3390/Ijms150915225 |
0.441 |
|
| 2014 |
Tajiri N, Acosta S, Portillo-Gonzales GS, Aguirre D, Reyes S, Lozano D, Pabon M, Dela Peña I, Ji X, Yasuhara T, Date I, Solomita MA, Antonucci I, Stuppia L, Kaneko Y, ... Borlongan CV, et al. Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke. Frontiers in Cellular Neuroscience. 8: 227. PMID 25165432 DOI: 10.3389/Fncel.2014.00227 |
0.462 |
|
| 2014 |
Gonzales-Portillo GS, Reyes S, Aguirre D, Pabon MM, Borlongan CV. Stem cell therapy for neonatal hypoxic-ischemic encephalopathy. Frontiers in Neurology. 5: 147. PMID 25161645 DOI: 10.3389/Fneur.2014.00147 |
0.409 |
|
| 2014 |
Tajiri N, Duncan K, Antoine A, Pabon M, Acosta SA, de la Pena I, Hernadez-Ontiveros DG, Shinozuka K, Ishikawa H, Kaneko Y, Yankee E, McGrogan M, Case C, Borlongan CV. Stem cell-paved biobridge facilitates neural repair in traumatic brain injury. Frontiers in Systems Neuroscience. 8: 116. PMID 25009475 DOI: 10.3389/Fnsys.2014.00116 |
0.811 |
|
| 2014 |
Pabon M, Tamboli C, Tamboli S, Acosta S, De La Pena I, Sanberg PR, Tajiri N, Kaneko Y, Borlongan CV. ESTROGEN REPLACEMENT THERAPY FOR STROKE. Cell Medicine. 6: 111-122. PMID 24999442 DOI: 10.3727/215517913X672263 |
0.329 |
|
| 2014 |
Tajiri N, Staples M, Kaneko Y, Kim SU, Zesiewicz TA, Borlongan CV. Autologous stem cell transplant with gene therapy for Friedreich ataxia. Medical Hypotheses. 83: 296-8. PMID 24962209 DOI: 10.1016/j.mehy.2014.05.022 |
0.315 |
|
| 2014 |
Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Sanberg PR, Sanchez-Ramos J, Song S, Kaneko Y, Borlongan CV. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. Plos One. 9: e90953. PMID 24621603 DOI: 10.1371/Journal.Pone.0090953 |
0.799 |
|
| 2014 |
Tajiri N, Quach DM, Kaneko Y, Wu S, Lee D, Lam T, Hayama KL, Hazel TG, Johe K, Wu MC, Borlongan CV. Behavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell lines. Plos One. 9: e91408. PMID 24614895 DOI: 10.1371/Journal.Pone.0091408 |
0.417 |
|
| 2014 |
Garbuzova-Davis S, Haller E, Williams SN, Haim ED, Tajiri N, Hernandez-Ontiveros DG, Frisina-Deyo A, Boffeli SM, Sanberg PR, Borlongan CV. Compromised blood-brain barrier competence in remote brain areas in ischemic stroke rats at the chronic stage. The Journal of Comparative Neurology. 522: 3120-37. PMID 24610730 DOI: 10.1002/Cne.23582 |
0.355 |
|
| 2014 |
Tajiri N, Hernandez D, Acosta S, Shinozuka K, Ishikawa H, Ehrhart J, Diamandis T, Gonzales-Portillo C, Borlongan MC, Tan J, Kaneko Y, Borlongan CV. Suppressed cytokine expression immediatey following traumatic brain injury in neonatal rats indicates an expeditious endogenous anti-inflammatory response. Brain Research. 1559: 65-71. PMID 24602693 DOI: 10.1016/J.Brainres.2014.02.041 |
0.778 |
|
| 2014 |
Gonzales-Portillo GS, Sanberg PR, Franzblau M, Gonzales-Portillo C, Diamandis T, Staples M, Sanberg CD, Borlongan CV. Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier. Cell Transplantation. 23: 531-9. PMID 24480552 DOI: 10.3727/096368914X678337 |
0.418 |
|
| 2014 |
Tajiri N, Acosta SA, Shahaduzzaman M, Ishikawa H, Shinozuka K, Pabon M, Hernandez-Ontiveros D, Kim DW, Metcalf C, Staples M, Dailey T, Vasconcellos J, Franyuti G, Gould L, Patel N, ... ... Borlongan CV, et al. Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 313-26. PMID 24381292 DOI: 10.1523/JNEUROSCI.2425-13.2014 |
0.8 |
|
| 2014 |
Kaneko Y, Shojo H, Burns J, Staples M, Tajiri N, Borlongan CV. DJ-1 ameliorates ischemic cell death in vitro possibly via mitochondrial pathway. Neurobiology of Disease. 62: 56-61. PMID 24060818 DOI: 10.1016/j.nbd.2013.09.007 |
0.356 |
|
| 2013 |
Dailey T, Metcalf C, Mosley YI, Sullivan R, Shinozuka K, Tajiri N, Pabon M, Acosta S, Kaneko Y, van Loveren H, Borlongan CV. An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside. Journal of Clinical Medicine. 2: 220-241. PMID 25177494 DOI: 10.3390/Jcm2040220 |
0.817 |
|
| 2013 |
Kaneko Y, Tajiri N, Shojo H, Borlongan CV. Oxygen-glucose-deprived rat primary neural cells exhibit DJ-1 translocation into healthy mitochondria: a potent stroke therapeutic target. Cns Neuroscience & Therapeutics. 20: 275-81. PMID 24382215 DOI: 10.1111/cns.12208 |
0.344 |
|
| 2013 |
Acosta SA, Diamond DM, Wolfe S, Tajiri N, Shinozuka K, Ishikawa H, Hernandez DG, Sanberg PR, Kaneko Y, Borlongan CV. Influence of post-traumatic stress disorder on neuroinflammation and cell proliferation in a rat model of traumatic brain injury. Plos One. 8: e81585. PMID 24349091 DOI: 10.1371/Journal.Pone.0081585 |
0.779 |
|
| 2013 |
Acosta SA, Franzese N, Staples M, Weinbren NL, Babilonia M, Patel J, Merchant N, Simancas AJ, Slakter A, Caputo M, Patel M, Franyuti G, Franzblau MH, Suarez L, Gonzales-Portillo C, ... ... Borlongan CV, et al. Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction. Journal of Stem Cell Research & Therapy. PMID 24307973 DOI: 10.4172/2157-7633.S4-005 |
0.797 |
|
| 2013 |
Tajiri N, Kellogg SL, Shimizu T, Arendash GW, Borlongan CV. Traumatic brain injury precipitates cognitive impairment and extracellular Aβ aggregation in Alzheimer's disease transgenic mice. Plos One. 8: e78851. PMID 24223856 DOI: 10.1371/Journal.Pone.0078851 |
0.754 |
|
| 2013 |
Dailey T, Mosley Y, Pabon M, Acosta S, Tajiri N, van Loveren H, Kaneko Y, Borlongan CV. Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy. Neuroreport. 24: 1067-71. PMID 24169604 DOI: 10.1097/Wnr.0000000000000062 |
0.433 |
|
| 2013 |
Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kaneko Y, Borlongan CV. Stem cell transplantation for neuroprotection in stroke. Brain Sciences. 3: 239-61. PMID 24147217 DOI: 10.3390/Brainsci3010239 |
0.823 |
|
| 2013 |
Ishikawa H, Tajiri N, Shinozuka K, Vasconcellos J, Kaneko Y, Lee HJ, Mimura O, Dezawa M, Kim SU, Borlongan CV. Vasculogenesis in experimental stroke after human cerebral endothelial cell transplantation. Stroke; a Journal of Cerebral Circulation. 44: 3473-81. PMID 24130140 DOI: 10.1161/Strokeaha.113.001943 |
0.818 |
|
| 2013 |
Yu S, Tajiri N, Franzese N, Franzblau M, Bae E, Platt S, Kaneko Y, Borlongan CV. Stem cell-like dog placenta cells afford neuroprotection against ischemic stroke model via heat shock protein upregulation. Plos One. 8: e76329. PMID 24086730 DOI: 10.1371/journal.pone.0076329 |
0.446 |
|
| 2013 |
Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kim DW, Pabon M, Acosta S, Kaneko Y, Borlongan CV. Stem Cells for Neurovascular Repair in Stroke. Journal of Stem Cell Research & Therapy. 4: 12912. PMID 24077523 DOI: 10.4172/2157-7633.S4-004 |
0.831 |
|
| 2013 |
Tajiri N, Kaneko Y, Shinozuka K, Ishikawa H, Yankee E, McGrogan M, Case C, Borlongan CV. Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. Plos One. 8: e74857. PMID 24023965 DOI: 10.1371/Journal.Pone.0074857 |
0.81 |
|
| 2013 |
Ishikawa H, Tajiri N, Vasconcellos J, Kaneko Y, Mimura O, Dezawa M, Borlongan CV. Ischemic stroke brain sends indirect cell death signals to the heart. Stroke; a Journal of Cerebral Circulation. 44: 3175-82. PMID 24008571 DOI: 10.1161/STROKEAHA.113.001714 |
0.349 |
|
| 2013 |
Dailey T, Tajiri N, Kaneko Y, Borlongan CV. Regeneration of neuronal cells following cerebral injury. Frontiers of Neurology and Neuroscience. 32: 54-61. PMID 23859963 DOI: 10.1159/000346407 |
0.406 |
|
| 2013 |
Shinozuka K, Staples M, Borlongan CV. Melatonin-based therapeutics for neuroprotection in stroke. International Journal of Molecular Sciences. 14: 8924-47. PMID 23698756 DOI: 10.3390/Ijms14058924 |
0.817 |
|
| 2013 |
Tajiri N, Dailey T, Metcalf C, Mosley YI, Lau T, Staples M, van Loveren H, Kim SU, Yamashima T, Yasuhara T, Date I, Kaneko Y, Borlongan CV. In vivo animal stroke models: a rationale for rodent and non-human primate models. Translational Stroke Research. 4: 308-21. PMID 23682299 DOI: 10.1007/s12975-012-0241-2 |
0.367 |
|
| 2013 |
Garbuzova-Davis S, Rodrigues MC, Hernandez-Ontiveros DG, Tajiri N, Frisina-Deyo A, Boffeli SM, Abraham JV, Pabon M, Wagner A, Ishikawa H, Shinozuka K, Haller E, Sanberg PR, Kaneko Y, Borlongan CV. Blood-brain barrier alterations provide evidence of subacute diaschisis in an ischemic stroke rat model. Plos One. 8: e63553. PMID 23675488 DOI: 10.1371/Journal.Pone.0063553 |
0.812 |
|
| 2013 |
Pabon MM, Borlongan CV. ADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY. Future Neurology. 8: 193-203. PMID 23565051 DOI: 10.2217/Fnl.12.85 |
0.462 |
|
| 2013 |
Kaneko Y, Pabon MM, Dailey T, Weinbren NL, Rizzi J, Tamboli C, Vasconcellos J, Kuzmin-Nichols N, Sanberg PR, Eve DJ, Tajiri N, Borlongan CV. The battle of the sexes for stroke therapy: female- versus male-derived stem cells. Cns & Neurological Disorders Drug Targets. 12: 405-12. PMID 23469849 DOI: 10.2174/1871527311312030013 |
0.454 |
|
| 2013 |
Ishikawa H, Caputo M, Franzese N, Weinbren NL, Slakter A, Patel M, Stahl CE, Jacotte MA, Acosta S, Franyuti G, Shinozuka K, Tajiri N, van Loveren H, Kaneko Y, Borlongan CV. Stroke in the eye of the beholder. Medical Hypotheses. 80: 411-5. PMID 23395299 DOI: 10.1016/J.Mehy.2012.12.030 |
0.801 |
|
| 2013 |
Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Grimmig B, Diamond DM, Diamond D, Sanberg PR, Bickford PC, Kaneko Y, Borlongan CV. Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. Plos One. 8: e53376. PMID 23301065 DOI: 10.1371/Journal.Pone.0053376 |
0.8 |
|
| 2013 |
Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan CV. Wharton's jelly-derived mesenchymal stem cells: Phenotypic characterization and Optimizing their therapeutic potential for clinical applications International Journal of Molecular Sciences. 14: 11692-11712. DOI: 10.3390/ijms140611692 |
0.781 |
|
| 2013 |
Dailey T, Eve DJ, Tajiri N, Lau T, Mosley Y, van Loveren H, Sanberg PR, Kaneko Y, Borlongan CV. Different sources of stem cells for transplantation therapy in stroke Cell-Based Therapies in Stroke. 29-46. DOI: 10.1007/978-3-7091-1175-8_3 |
0.409 |
|
| 2012 |
Rodrigues MC, Dmitriev D, Rodrigues A, Glover LE, Sanberg PR, Allickson JG, Kuzmin-Nichols N, Tajiri N, Shinozuka K, Garbuzova-Davis S, Kaneko Y, Borlongan CV. Menstrual blood transplantation for ischemic stroke: Therapeutic mechanisms and practical issues. Interventional Medicine & Applied Science. 4: 59-68. PMID 25267932 DOI: 10.1556/Imas.4.2012.2.1 |
0.83 |
|
| 2012 |
Sanberg PR, Eve DJ, Metcalf C, Borlongan CV. Advantages and challenges of alternative sources of adult-derived stem cells for brain repair in stroke. Progress in Brain Research. 201: 99-117. PMID 23186712 DOI: 10.1016/B978-0-444-59544-7.00006-8 |
0.421 |
|
| 2012 |
Kaneko Y, Tajiri N, Yu S, Hayashi T, Stahl CE, Bae E, Mestre H, Franzese N, Rodrigues A, Rodrigues MC, Ishikawa H, Shinozuka K, Hethorn W, Weinbren N, Glover LE, ... ... Borlongan CV, et al. Nestin overexpression precedes caspase-3 upregulation in rats exposed to controlled cortical impact traumatic brain injury. Cell Medicine. 4: 55-63. PMID 23101029 DOI: 10.3727/215517912X639306 |
0.795 |
|
| 2012 |
Kaneko Y, Tajiri N, Su TP, Wang Y, Borlongan CV. Combination treatment of hypothermia and mesenchymal stromal cells amplifies neuroprotection in primary rat neurons exposed to hypoxic-ischemic-like injury in vitro: role of the opioid system. Plos One. 7: e47583. PMID 23077646 DOI: 10.1371/journal.pone.0047583 |
0.339 |
|
| 2012 |
Tajiri N, Acosta S, Glover LE, Bickford PC, Jacotte Simancas A, Yasuhara T, Date I, Solomita MA, Antonucci I, Stuppia L, Kaneko Y, Borlongan CV. Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. Plos One. 7: e43779. PMID 22912905 DOI: 10.1371/journal.pone.0043779 |
0.436 |
|
| 2012 |
Kaneko Y, Cortes L, Sanberg C, Acosta S, Bickford PC, Borlongan CV. Dietary supplementations as neuroprotective therapies: focus on NT-020 diet benefits in a rat model of stroke. International Journal of Molecular Sciences. 13: 7424-44. PMID 22837703 DOI: 10.3390/ijms13067424 |
0.348 |
|
| 2012 |
Borlongan CV. Recent preclinical evidence advancing cell therapy for Alzheimer's disease. Experimental Neurology. 237: 142-6. PMID 22766481 DOI: 10.1016/j.expneurol.2012.06.024 |
0.345 |
|
| 2012 |
Borlongan CV. The blood brain barrier in stroke. Current Pharmaceutical Design. 18: 3613-4. PMID 22734824 DOI: 10.2174/138161212802002751 |
0.328 |
|
| 2012 |
Kaneko Y, Tajiri N, Shinozuka K, Glover LE, Weinbren NL, Cortes L, Borlongan CV. Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells. Current Pharmaceutical Design. 18: 3731-4. PMID 22574986 DOI: 10.2174/138161212802002733 |
0.822 |
|
| 2012 |
Borlongan CV, Glover LE, Sanberg PR, Hess DC. Permeating the blood brain barrier and Abrogating the inflammation in stroke: Implications for stroke therapy Current Pharmaceutical Design. 18: 3670-3676. PMID 22574981 DOI: 10.2174/138161212802002841 |
0.448 |
|
| 2012 |
Tajiri N, Lau T, Glover LE, Shinozuka K, Kaneko Y, van Loveren H, Borlongan CV. Cerebral aneurysm as an exacerbating factor in stroke pathology and a therapeutic target for neuroprotection. Current Pharmaceutical Design. 18: 3663-9. PMID 22574980 DOI: 10.2174/138161212802002724 |
0.815 |
|
| 2012 |
Borlongan CV, Rodrigues AA, Oliveira MC. Breaking the barrier in stroke: What Should we know? A mini-review Current Pharmaceutical Design. 18: 3615-3623. PMID 22574976 DOI: 10.2174/138161212802002670 |
0.377 |
|
| 2012 |
Toyoda T, Matsukawa N, Sagisaka T, Uematsu N, Kanamori T, Kato D, Mizuno M, Wake H, Hida H, Borlongan CV, Ojika K. Suppression of astrocyte lineage in adult hippocampal progenitor cells expressing hippocampal cholinergic neurostimulating Peptide precursor in an in vivo ischemic model. Cell Transplantation. 21: 2159-69. PMID 22469272 DOI: 10.3727/096368911X627543 |
0.325 |
|
| 2012 |
Glover LE, Tajiri N, Weinbren NL, Ishikawa H, Shinozuka K, Kaneko Y, Watterson DM, Borlongan CV. A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells. Translational Stroke Research. 3: 90-8. PMID 22389662 DOI: 10.1007/S12975-011-0127-8 |
0.832 |
|
| 2012 |
Sanberg PR, Eve DJ, Cruz LE, Borlongan CV. Neurological disorders and the potential role for stem cells as a therapy. British Medical Bulletin. 101: 163-81. PMID 22357552 DOI: 10.1093/Bmb/Lds001 |
0.335 |
|
| 2012 |
Antonucci I, Pantalone A, Tete S, Salini V, Borlongan CV, Hess D, Stuppia L. Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. Current Pharmaceutical Design. 18: 1846-63. PMID 22352751 DOI: 10.2174/138161212799859602 |
0.374 |
|
| 2012 |
Rodrigues MC, Voltarelli J, Sanberg PR, Allickson JG, Kuzmin-Nichols N, Garbuzova-Davis S, Borlongan CV. Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke. Neuroscience and Biobehavioral Reviews. 36: 177-90. PMID 21645544 DOI: 10.1016/J.Neubiorev.2011.05.010 |
0.414 |
|
| 2011 |
Rodrigues MC, Glover LE, Weinbren N, Rizzi JA, Ishikawa H, Shinozuka K, Tajiri N, Kaneko Y, Sanberg PR, Allickson JG, Kuzmin-Nichols N, Garbuzova-Davis S, Voltarelli JC, Cruz E, Borlongan CV. Toward personalized cell therapies: autologous menstrual blood cells for stroke. Journal of Biomedicine & Biotechnology. 2011: 194720. PMID 22162629 DOI: 10.1155/2011/194720 |
0.829 |
|
| 2011 |
Borlongan CV, Glover LE, Tajiri N, Kaneko Y, Freeman TB. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Progress in Neurobiology. 95: 213-28. PMID 21903148 DOI: 10.1016/j.pneurobio.2011.08.005 |
0.45 |
|
| 2011 |
Borlongan CV. Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all! Leukemia. 25: 1674-86. PMID 21727900 DOI: 10.1038/leu.2011.167 |
0.405 |
|
| 2011 |
Allickson JG, Sanchez A, Yefimenko N, Borlongan CV, Sanberg PR. Recent Studies Assessing the Proliferative Capability of a Novel Adult Stem Cell Identified in Menstrual Blood. The Open Stem Cell Journal. 3: 4-10. PMID 21686032 DOI: 10.2174/1876893801103010004 |
0.316 |
|
| 2011 |
Borlongan CV, Weiss MD. Baby STEPS: a giant leap for cell therapy in neonatal brain injury. Pediatric Research. 70: 3-9. PMID 21659957 DOI: 10.1203/PDR.0b013e31821d0d00 |
0.366 |
|
| 2011 |
Osman MM, Lulic D, Glover L, Stahl CE, Lau T, van Loveren H, Borlongan CV. Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application. Neuropeptides. 45: 359-68. PMID 21592568 DOI: 10.1016/j.npep.2011.04.002 |
0.369 |
|
| 2011 |
Manuelpillai U, Moodley Y, Borlongan C, Parolini O. Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta. 32: 320-325. PMID 21570115 DOI: 10.1016/J.Placenta.2011.04.010 |
0.372 |
|
| 2011 |
Emerich DF, Orive G, Borlongan C. Tales of biomaterials, molecules, and cells for repairing and treating brain dysfunction. Current Stem Cell Research & Therapy. 6: 171-89. PMID 21476979 DOI: 10.2174/157488811796575350 |
0.322 |
|
| 2011 |
Morimoto T, Yasuhara T, Kameda M, Baba T, Kuramoto S, Kondo A, Takahashi K, Tajiri N, Wang F, Meng J, Ji YW, Kadota T, Maruo T, Kinugasa K, Miyoshi Y, ... ... Borlongan CV, et al. Striatal stimulation nurtures endogenous neurogenesis and angiogenesis in chronic-phase ischemic stroke rats. Cell Transplantation. 20: 1049-64. PMID 21092409 DOI: 10.3727/096368910X544915 |
0.328 |
|
| 2011 |
Antonucci I, Stuppia L, Kaneko Y, Yu S, Tajiri N, Bae EC, Chheda SH, Weinbren NL, Borlongan CV. Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplantation. 20: 789-95. PMID 21054947 DOI: 10.3727/096368910X539074 |
0.328 |
|
| 2011 |
Sanberg PR, Eve DJ, Willing AE, Garbuzova-Davis S, Tan J, Sanberg CD, Allickson JG, Cruz LE, Borlongan CV. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplantation. 20: 85-94. PMID 20887684 DOI: 10.3727/096368910X532855 |
0.34 |
|
| 2011 |
Park DH, Lee JH, Borlongan CV, Sanberg PR, Chung YG, Cho TH. Transplantation of umbilical cord blood stem cells for treating spinal cord injury. Stem Cell Reviews. 7: 181-94. PMID 20532836 DOI: 10.1007/S12015-010-9163-0 |
0.312 |
|
| 2011 |
Borlongan C, Zeitlin A, Hariri R, Pal A. Cell therapy for stroke: towards clinical application of Celgene human placenta-derived cells Placenta. 32: S331. DOI: 10.1016/J.PLACENTA.2011.07.046 |
0.387 |
|
| 2010 |
Sanberg PR, Borlongan CV. Announcing a New Open Access Journal: Cell Medicine, Part B of Cell Transplantation. Cell Medicine. 1: 1-2. PMID 26998395 DOI: 10.3727/215517910X486334 |
0.302 |
|
| 2010 |
Kaneko Y, Eve DJ, Yu S, Shojo H, Bae EC, Park DH, Roschek B, Alberte RS, Sanberg PR, Sanberg CD, Bickford PC, Borlongan CV. Acute Treatment With Herbal Extracts Provides Neuroprotective Benefits in In Vitro and In Vivo Stroke Models, Characterized by Reduced Ischemic Cell Death and Maintenance of Motor and Neurological Functions. Cell Medicine. 1: 137-142. PMID 21379315 DOI: 10.3727/215517910X552818 |
0.384 |
|
| 2010 |
Eve DJ, Fillmore RW, Borlongan CV, Sanberg PR. Stem cell research in cell transplantation: sources, geopolitical influence, and transplantation. Cell Transplantation. 19: 1493-509. PMID 21054954 DOI: 10.3727/096368910X540612 |
0.319 |
|
| 2010 |
Ou Y, Yu S, Kaneko Y, Tajiri N, Bae EC, Chheda SH, Stahl CE, Yang T, Fang L, Hu K, Borlongan CV, Yu G. Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats. Brain Research. 1366: 217-25. PMID 20888805 DOI: 10.1016/j.brainres.2010.09.098 |
0.32 |
|
| 2010 |
Yasuhara T, Hara K, Maki M, Xu L, Yu G, Ali MM, Masuda T, Yu SJ, Bae EK, Hayashi T, Matsukawa N, Kaneko Y, Kuzmin-Nichols N, Ellovitch S, Cruz EL, ... ... Borlongan CV, et al. Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts Journal of Cellular and Molecular Medicine. 14: 914-921. PMID 20569276 DOI: 10.1111/J.1582-4934.2008.00671.X |
0.372 |
|
| 2010 |
Bachstetter AD, Jernberg J, Schlunk A, Vila JL, Hudson C, Cole MJ, Shytle RD, Tan J, Sanberg PR, Sanberg CD, Borlongan C, Kaneko Y, Tajiri N, Gemma C, Bickford PC. Spirulina promotes stem cell genesis and protects against LPS induced declines in neural stem cell proliferation. Plos One. 5: e10496. PMID 20463965 DOI: 10.1371/Journal.Pone.0010496 |
0.434 |
|
| 2010 |
Borlongan CV, Kaneko Y, Maki M, Yu SJ, Ali M, Allickson JG, Sanberg CD, Kuzmin-Nichols N, Sanberg PR. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells and Development. 19: 439-52. PMID 19860544 DOI: 10.1089/Scd.2009.0340 |
0.424 |
|
| 2010 |
Mays RW, Borlongan CV, Yasuhara T, Hara K, Maki M, Carroll JE, Deans RJ, Hess DC. Development of an allogeneic adherent stem cell therapy for treatment of ischemic stroke Journal of Experimental Stroke and Translational Medicine. 3: 34-46. DOI: 10.6030/1939-067X-3.1.34 |
0.417 |
|
| 2009 |
Matsukawa N, Yasuhara T, Hara K, Xu L, Maki M, Yu G, Kaneko Y, Ojika K, Hess DC, Borlongan CV. Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. Bmc Neuroscience. 10: 126. PMID 19807907 DOI: 10.1186/1471-2202-10-126 |
0.321 |
|
| 2009 |
Chopp M, Steinberg GK, Kondziolka D, Lu M, Bliss TM, Li Y, Hess DC, Borlongan CV. Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplantation. 18: 691-3. PMID 19796499 DOI: 10.3727/096368909X470883 |
0.409 |
|
| 2009 |
Park DH, Borlongan CV, Willing AE, Eve DJ, Cruz LE, Sanberg CD, Chung YG, Sanberg PR. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplantation. 18: 985-98. PMID 19523333 DOI: 10.3727/096368909X471279 |
0.434 |
|
| 2009 |
Yu SJ, Soncini M, Kaneko Y, Hess DC, Parolini O, Borlongan CV. Amnion: a potent graft source for cell therapy in stroke. Cell Transplantation. 18: 111-8. PMID 19499700 DOI: 10.3727/096368909788341243 |
0.388 |
|
| 2009 |
Yasuhara T, Matsukawa N, Hara K, Maki M, Ali MM, Yu SJ, Bae E, Yu G, Xu L, McGrogan M, Bankiewicz K, Case C, Borlongan CV. Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells and Development. 18: 1501-14. PMID 19301956 DOI: 10.1089/scd.2009.0011 |
0.405 |
|
| 2009 |
Park DH, Eve DJ, Musso J, Klasko SK, Cruz E, Borlongan CV, Sanberg PR. Inflammation and stem cell migration to the injured brain in higher organisms. Stem Cells and Development. 18: 693-702. PMID 19199787 DOI: 10.1089/Scd.2009.0008 |
0.378 |
|
| 2009 |
Park DH, Eve DJ, Borlongan CV, Klasko SK, Cruz LE, Sanberg PR. From the basics to application of cell therapy, a steppingstone to the conquest of neurodegeneration: a meeting report. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 15: RA23-31. PMID 19179980 |
0.362 |
|
| 2009 |
Yu G, Borlongan CV, Stahl CE, Hess DC, Ou Y, Kaneko Y, Yu SJ, Yang T, Fang L, Xie X. Systemic delivery of umbilical cord blood cells for stroke therapy: a review. Restorative Neurology and Neuroscience. 27: 41-54. PMID 19164852 DOI: 10.3233/RNN-2009-0460 |
0.351 |
|
| 2009 |
Carroll JE, Borlongan CV. Adult stem cell therapy for acute brain injury in children. Cns & Neurological Disorders Drug Targets. 7: 361-9. PMID 18991664 DOI: 10.2174/187152708786441812 |
0.393 |
|
| 2008 |
Borlongan CV. Cell therapy for stroke: remaining issues to address before embarking on clinical trials. Stroke. 40: S146-8. PMID 19064801 DOI: 10.1161/STROKEAHA.108.533091 |
0.426 |
|
| 2008 |
Hess DC, Borlongan CV. Cell-based therapy in ischemic stroke. Expert Review of Neurotherapeutics. 8: 1193-201. PMID 18671663 DOI: 10.1586/14737175.8.8.1193 |
0.443 |
|
| 2008 |
Yasuhara T, Hara K, Maki M, Mays RW, Deans RJ, Hess DC, Carroll JE, Borlongan CV. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats Journal of Cerebral Blood Flow and Metabolism. 28: 1804-1810. PMID 18594556 DOI: 10.1038/jcbfm.2008.68 |
0.383 |
|
| 2008 |
Hara K, Yasuhara T, Maki M, Matsukawa N, Masuda T, Yu SJ, Ali M, Yu G, Xu L, Kim SU, Hess DC, Borlongan CV. Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Progress in Neurobiology. 85: 318-34. PMID 18514379 DOI: 10.1016/j.pneurobio.2008.04.005 |
0.415 |
|
| 2008 |
Yasuhara T, Hara K, Maki M, Masuda T, Sanberg CD, Sanberg PR, Bickford PC, Borlongan CV. Dietary supplementation exerts neuroprotective effects in ischemic stroke model. Rejuvenation Research. 11: 201-14. PMID 18260778 DOI: 10.1089/Rej.2007.0608 |
0.395 |
|
| 2008 |
Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Proliferation. 94-114. PMID 18181951 DOI: 10.1111/j.1365-2184.2008.00486.x |
0.391 |
|
| 2008 |
Borlongan CV. Stroke recovery with cellular therapies The Lancet Neurology. 7: 680-681. DOI: 10.1016/S1474-4422(08)70159-5 |
0.327 |
|
| 2007 |
Tang Y, Yasuhara T, Hara K, Matsukawa N, Maki M, Yu G, Xu L, Hess DC, Borlongan CV. Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. Cell Transplantation. 16: 159-69. PMID 17474297 |
0.426 |
|
| 2007 |
Hara K, Matsukawa N, Yasuhara T, Xu L, Yu G, Maki M, Kawase T, Hess DC, Kim SU, Borlongan CV. Transplantation of post-mitotic human neuroteratocarcinoma-overexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: in vitro evidence of expedited neuronal differentiation and GDNF secretion. Journal of Neuroscience Research. 85: 1240-51. PMID 17335085 DOI: 10.1002/jnr.21234 |
0.437 |
|
| 2007 |
Tang Y, Yasuhara T, Hara K, Matsukawa N, Maki M, Yu G, Xu L, Hess DC, Borlongan CV. Transplantation of Bone Marrow-Derived Stem Cells: A Promising Therapy for Stroke Cell Transplantation. 16: 159-169. DOI: 10.3727/000000007783464614 |
0.367 |
|
| 2007 |
Sanberg PR, English DK, Hakki A, Cameron DF, Garbuzova-Davis S, Willing AE, Borlongan CV, Henning R, Klasko SK, El-Badri NS. Concepts in Cell Therapy: From Cord Blood to Sertoli Cells Cellular Transplantation. 547-566. DOI: 10.1016/B978-012369415-7/50030-2 |
0.322 |
|
| 2007 |
Borlongan CV, Stahl CE, Yu G, Xu L, Yasuhara T, Hara K, Matsukawa N, Sanberg PR, Wang Y, Hess DC. NT2N Cell Transplantation and GDNF Treatment in Stroke: Linking Neurotrophic Factor Therapy and Neuroprotection Cellular Transplantation. 353-371. DOI: 10.1016/B978-012369415-7/50021-1 |
0.379 |
|
| 2006 |
Garbuzova-Davis S, Willing AE, Saporta S, Bickford PC, Gemma C, Chen N, Sanberg CD, Klasko SK, Borlongan CV, Sanberg PR. Novel cell therapy approaches for brain repair. Progress in Brain Research. 157: 207-22. PMID 17046673 DOI: 10.1016/S0079-6123(06)57014-1 |
0.362 |
|
| 2006 |
Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, Fagan SC. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. Bmc Neuroscience. 7: 56. PMID 16846501 DOI: 10.1186/1471-2202-7-56 |
0.312 |
|
| 2006 |
Yasuhara T, Matsukawa N, Yu G, Xu L, Mays RW, Kovach J, Deans RJ, Hess DC, Carroll JE, Borlongan CV. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury Cell Transplantation. 15: 231-238. PMID 16719058 DOI: 10.3727/000000006783982034 |
0.38 |
|
| 2006 |
Yasuhara T, Matsukawa N, Yu G, Xu L, Mays RW, Kovach J, Deans R, Hess DC, Carroll JE, Borlongan CV. Transplantation of cryopreserved human bone marrow-derived multipotent adult progenitor cells for neonatal hypoxic-ischemic injury: Targeting the hippocampus Reviews in the Neurosciences. 17: 215-225. PMID 16703953 DOI: 10.1515/revneuro.2006.17.1-2.215 |
0.37 |
|
| 2006 |
Borlongan CV, Hess DC. New hope for stroke patients: mobilization of endogenous stem cells. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 174: 954-5. PMID 16517763 DOI: 10.1503/cmaj.060199 |
0.382 |
|
| 2006 |
Xia CF, Yin H, Yao YY, Borlongan CV, Chao L, Chao J. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Human Gene Therapy. 17: 206-19. PMID 16454654 DOI: 10.1089/Hum.2006.17.206 |
0.342 |
|
| 2006 |
Wang Y, Alexander OB, Woodward-Pu YM, Stahl CE, Borlongan CV. Viral vector strategy for glial cell line-derived neurotrophic factor therapy for stroke. Frontiers in Bioscience : a Journal and Virtual Library. 11: 1101-7. PMID 16146800 DOI: 10.2741/1866 |
0.372 |
|
| 2006 |
Borlongan CV, Fournier C, Stahl CE, Yu G, Xu L, Matsukawa N, Newman M, Yasuhara T, Hara K, Hess DC, Sanberg PR. Gene therapy, cell transplantation and stroke. Frontiers in Bioscience : a Journal and Virtual Library. 11: 1090-101. PMID 16146799 DOI: 10.2741/1865 |
0.415 |
|
| 2006 |
Yasuhara T, Borlongan CV, Date I. Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia. Frontiers in Bioscience : a Journal and Virtual Library. 11: 760-75. PMID 16146768 |
0.397 |
|
| 2005 |
Borlongan CV, Evans A, Yu G, Hess DC. Limitations of intravenous human bone marrow CD133+ cell grafts in stroke rats. Brain Research. 1048: 116-22. PMID 15921661 DOI: 10.1016/j.brainres.2005.04.087 |
0.337 |
|
| 2005 |
Borlongan CV, Sumaya IC, Moss DE. Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats. Brain Research. 1038: 50-8. PMID 15748872 DOI: 10.1016/j.brainres.2005.01.028 |
0.325 |
|
| 2005 |
Newman MB, Misiuta I, Willing AE, Zigova T, Karl RC, Borlongan CV, Sanberg PR. Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells and Development. 14: 29-43. PMID 15725742 DOI: 10.1089/Scd.2005.14.29 |
0.356 |
|
| 2005 |
Stern DM, Hess DC, Borlongan CV. Healing a broken heart with stem cells. Cell Transplantation. 13: 725-7. PMID 15690973 DOI: 10.3727/000000004783983468 |
0.319 |
|
| 2004 |
Newman MB, Emerich DF, Borlongan CV, Sanberg CD, Sanberg PR. Use of human umbilical cord blood (HUCB) cells to repair the damaged brain. Current Neurovascular Research. 1: 269-81. PMID 16181077 DOI: 10.2174/1567202043362261 |
0.305 |
|
| 2004 |
Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke Stroke. 35: 2385-2389. PMID 15345799 DOI: 10.1161/01.Str.0000141680.49960.D7 |
0.409 |
|
| 2004 |
Yu G, Hess DC, Borlongan CV. Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke. Brain Research. 1018: 32-7. PMID 15262202 DOI: 10.1016/j.brainres.2004.05.056 |
0.305 |
|
| 2004 |
Borlongan CV, Skinner SJ, Geaney M, Vasconcellos AV, Elliott RB, Emerich DF. CNS grafts of rat choroid plexus protect against cerebral ischemia in adult rats. Neuroreport. 15: 1543-7. PMID 15232280 DOI: 10.1097/01.wnr.0000133298.84901.cf |
0.364 |
|
| 2004 |
Yu G, Xu L, Hadman M, Hess DC, Borlongan CV. Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion. Brain Research. 1015: 50-6. PMID 15223366 DOI: 10.1016/j.brainres.2004.04.055 |
0.363 |
|
| 2004 |
Irons H, Lind JG, Wakade CG, Yu G, Hadman M, Carroll J, Hess DC, Borlongan CV. Intracerebral xenotransplantation of GFP mouse bone marrow stromal cells in intact and stroke rat brain: graft survival and immunologic response. Cell Transplantation. 13: 283-94. PMID 15191166 DOI: 10.3727/000000004783983990 |
0.344 |
|
| 2004 |
Borlongan CV, Lind JG, Dillon-Carter O, Yu G, Hadman M, Cheng C, Carroll J, Hess DC. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Research. 1010: 108-16. PMID 15126123 DOI: 10.1016/j.brainres.2004.02.072 |
0.362 |
|
| 2004 |
Newman MB, Davis CD, Borlongan CV, Emerich D, Sanberg PR. Transplantation of human umbilical cord blood cells in the repair of CNS diseases. Expert Opinion On Biological Therapy. 4: 121-30. PMID 14998772 DOI: 10.1517/14712598.4.2.121 |
0.314 |
|
| 2003 |
Borlongan CV, Sumaya I, Moss D, Kumazaki M, Sakurai T, Hida H, Nishino H. Melatonin-secreting pineal gland: a novel tissue source for neural transplantation therapy in stroke. Cell Transplantation. 12: 225-34. PMID 12797377 DOI: 10.3727/000000003108746786 |
0.356 |
|
| 2002 |
Dillon-Carter O, Johnston RE, Borlongan CV, Truckenmiller ME, Coggiano M, Freed WJ. T155g-immortalized kidney cells produce growth factors and reduce sequelae of cerebral ischemia. Cell Transplantation. 11: 251-9. PMID 12075990 |
0.341 |
|
| 2001 |
Wang Y, Hayashi T, Chang C, Chiang Y, Tsao L, Su T, Borlongan C, Lin S. Methamphetamine Potentiates Ischemia/Reperfusion Insults After Transient Middle Cerebral Artery Ligation Stroke. 32: 775-782. PMID 11239201 DOI: 10.1161/01.Str.32.3.775 |
0.415 |
|
| 2001 |
Nishino H, Borlongan CV. Restoration of function by neural transplantation in the ischemic brain. Progress in Brain Research. 127: 461-76. PMID 11142041 DOI: 10.1016/S0079-6123(00)27022-2 |
0.416 |
|
| 2000 |
Borlongan CV, Yamamoto M, Takei N, Kumazaki M, Ungsuparkorn C, Hida H, Sanberg PR, Nishino H. Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 14: 1307-17. PMID 10877823 DOI: 10.1096/Fj.14.10.1307 |
0.312 |
|
| 2000 |
Tomac AC, Grinberg A, Huang SP, Nosrat C, Wang Y, Borlongan C, Lin SZ, Chiang YH, Olson L, Westphal H, Hoffer BJ. Glial cell line-derived neurotrophic factor receptor alpha1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles. Neuroscience. 95: 1011-23. PMID 10682708 DOI: 10.1016/S0306-4522(99)00503-5 |
0.315 |
|
| 2000 |
Borlongan CV, Stahl CE, Keep MF, Elmér E, Watanabe S. Cyclosporine-A enhances choline acetyltransferase immunoreactivity in the septal region of adult rats. Neuroscience Letters. 279: 73-6. PMID 10674624 DOI: 10.1016/S0304-3940(99)00962-3 |
0.571 |
|
| 1999 |
Borlongan CV, Kwanbara Y, Fujisaki T, Watanabe S. Cyclosporine-A reduces spontaneous place preference in adult rats Neuroscience Letters. 267: 169-172. PMID 10381003 DOI: 10.1016/S0304-3940(99)00357-2 |
0.524 |
|
| 1999 |
Borlongan CV, Stahl CE, Fujisaki T, Sanberg PR, Watanabe S. Cyclosporine A-induced hyperactivity in rats: is it mediated by immunosuppression, neurotrophism, or both? Cell Transplantation. 8: 153-9. PMID 10338283 DOI: 10.1177/096368979900800107 |
0.561 |
|
| 1999 |
Borlongan CV, Fujisaki T, Watanabe S. Chronic cyclosporine-A injection in rats with damaged blood-brain barrier does not impair retention of passive avoidance. Neuroscience Research. 32: 195-200. PMID 9875561 DOI: 10.1016/S0168-0102(98)00088-1 |
0.574 |
|
| 1999 |
Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR. Cerebral ischemia and CNS transplantation: differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line. Neuroreport. 9: 3703-9. PMID 9858383 DOI: 10.1097/00001756-199811160-00025 |
0.352 |
|
| 1998 |
Borlongan CV, Saporta S, Sanberg PR. Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats. Experimental Neurology. 151: 203-14. PMID 9628755 DOI: 10.1006/Exnr.1998.6790 |
0.307 |
|
| 1998 |
Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Experimental Neurology. 149: 310-21. PMID 9500961 DOI: 10.1006/Exnr.1997.6730 |
0.354 |
|
| 1997 |
Saporta S, Borlongan C, Moore J, Mejia-Millan E, Jones SL, Bonness P, Randall TS, Allen RC, Freeman TB, Sanberg PR. Microcarrier enhanced survival of human and rat fetal ventral mesencephalon cells implanted in the rat striatum. Cell Transplantation. 6: 579-84. PMID 9440867 DOI: 10.1016/S0963-6897(97)00115-2 |
0.335 |
|
| 1997 |
Borlongan CV, Watanabe S. Footshock facilitates discrimination of stimulus properties of morphine. Life Sciences. 61: 1045-9. PMID 9307049 DOI: 10.1016/S0024-3205(97)00612-7 |
0.496 |
|
| 1997 |
Borlongan CV, Fujisaki T, Watanabe S. Chronic administration of cyclosporine A does not impair memory retention in rats. Neuroreport. 8: 673-676. PMID 9106745 DOI: 10.1097/00001756-199702100-00019 |
0.556 |
|
| 1996 |
Sanberg PR, Borlongan CV, Saporta S, Cameron DF. Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nature Biotechnology. 14: 1692-5. PMID 9634853 DOI: 10.1038/Nbt1296-1692 |
0.301 |
|
| 1995 |
Borlongan CV, Watanabe S. A rapid assessment of stimulus properties of morphine. Life Sciences. 57: PL171-4. PMID 7674816 DOI: 10.1016/0024-3205(95)02081-S |
0.481 |
|
| 1995 |
Watanabe S, Inada S, Borlongan C. Factor of familiarity in sibling recognition in golden hamsters Journal of Ethology. 13: 17-22. DOI: 10.1007/Bf02352558 |
0.53 |
|
| 1994 |
Borlongan CV, Watanabe S. Failure to discriminate conspecifics in amygdaloid-lesioned mice. Pharmacology, Biochemistry, and Behavior. 48: 677-80. PMID 7938122 DOI: 10.1016/0091-3057(94)90331-X |
0.497 |
|
| Show low-probability matches. |